| Product No. | Product Name | Type | Applications | Size |
| 01-07-0101 | Anti-H (Shanghai-191)(MeV) | IgG | Neut., WB, ELISA, IP, IF | 100 μg |
| 01-07-0102 | Anti-H (Shanghai-191)(MeV) | IgG1 | Neut., WB, ELISA, IP, IF | 100 μg |
| 01-07-0103 | Anti-H (Shanghai-191)(MeV) | IgG1 | ELISA, IP, IF | 100 μg |
| 01-07-0104 | Anti-F (Shanghai-191)(MeV) | IgG | WB, ELISA, IP, IF | 100 μg |
| 01-07-0105 | Anti-F (Shanghai-191)(MeV) | IgG1 | WB, ELISA, IP, IF | 100 μg |
| 01-07-0106 | Anti-F (Shanghai-191)(MeV) | IgG1 | ELISA, IP, IF | 100 μg |
| 01-07-0107 | Anti-HN (Jeryl Lynn)(MuV) | IgG | Neut., WB, ELISA, IP, IF | 100 μg |
| 01-07-0108 | Anti-HN (Jeryl Lynn)(MuV) | IgG1 | WB, ELISA, IP, IF | 100 μg |
| 01-07-0109 | Anti-HN (Jeryl Lynn)(MuV) | IgG1 | ELISA, IP, IF | 100 μg |
| 01-07-0110 | Anti-F (Jeryl Lynn)(MuV) | IgG | WB, ELISA, IP, IF | 100 μg |
| 01-07-0111 | Anti-F (Jeryl Lynn)(MuV) | IgG1 | WB, ELISA, IP, IF | 100 μg |
| 01-07-0112 | Anti-F (Jeryl Lynn)(MuV) | IgG1 | ELISA, IP, IF | 100 μg |
| 01-07-0113 | Anti-G (Strain A2)(RSV) | IgG | Neut., WB, ELISA, IP, IF | 100 μg |
| 01-07-0114 | Anti-G (Strain A2)(RSV) | IgG1 | WB, ELISA, IP, IF | 100 μg |
| 01-07-0115 | Anti-G (Strain A2)(RSV) | IgG1 | ELISA, IP, IF | 100 μg |
| 01-07-0116 | Anti-F (Strain A2)(RSV) | IgG | WB, ELISA, IP, IF | 100 μg |
| 01-07-0117 | Anti-F (Strain A2)(RSV) | IgG1 | WB, ELISA, IP, IF | 100 μg |
| 01-07-0118 | Anti-F (Strain A2)(RSV) | IgG1 | ELISA, IP, IF | 100 μg |
| 01-07-0119 | Anti-F (RSV) AM14 (human Fc) | IgG1 | Neutralization, ELISA, IF, etc. | 100 μg |
| 01-07-0120 | Anti-F (RSV) D25 (human Fc) | IgG1 | Neutralization, ELISA, IF, etc. | 100 μg |
| 01-07-0121 | Anti-F (RSV) motavizumab | IgG1 | Neut., ELISA, IP, IF | 100 μg |
| 01-07-0122 | Anti-HN (Washington/1964)(HPIV-1) | IgG | Neut., WB, ELISA, IP, IF | 100 μg |
| 01-07-0123 | Anti-HN (Washington/1964)(HPIV-1) | IgG1 | WB, ELISA, IP, IF | 100 μg |
| 01-07-0124 | Anti-HN (Washington/1964)(HPIV-1) | IgG1 | ELISA, IP, IF | 100 μg |
| 01-07-0125 | Anti-F (Washington/1964)(HPIV-1) | IgG | WB, ELISA, IP, IF | 100 μg |
| 01-07-0126 | Anti-F (Washington/1964)(HPIV-1) | IgG1 | WB, ELISA, IP, IF | 100 μg |
| 01-07-0127 | Anti-F (Washington/1964)(HPIV-1) | IgG1 | ELISA, IP, IF | 100 μg |
| 01-07-0128 | Anti-HN (strain NIH 47885)(HPIV-3) | IgG | Neut., WB, ELISA, IP, IF | 100 μg |
| 01-07-0129 | Anti-HN (strain NIH 47885)(HPIV-3) | IgG1 | WB, ELISA, IP, IF | 100 μg |
| 01-07-0130 | Anti-HN (strain NIH 47885)(HPIV-3) | IgG1 | ELISA, IP, IF | 100 μg |
| 01-07-0131 | Anti-F (strain NIH 47885)(HPIV-3) | IgG | WB, ELISA, IP, IF | 100 μg |
| 01-07-0132 | Anti-F (strain NIH 47885)(HPIV-3) | IgG1 | WB, ELISA, IP, IF | 100 μg |
| 01-07-0133 | Anti-F (strain NIH 47885)(HPIV-3) | IgG1 | ELISA, IP, IF | 100 μg |
| 01-07-0134 | Anti-G(ΔTM)(Strain CAN97-83)(hMPV) | IgG | Neut., WB, ELISA, IP, IF | 100 μg |
| 01-07-0135 | Anti-G(ΔTM)(Strain CAN97-83)(hMPV) | IgG1 | WB, ELISA, IP, IF | 100 μg |
| 01-07-0136 | Anti-G(ΔTM)(Strain CAN97-83)(hMPV) | IgG1 | ELISA, IP, IF | 100 μg |
| 01-07-0137 | Anti-F G(ΔTM)(Strain CAN97-83)(hMPV) | IgG | Neut., WB, ELISA, IP, IF | 100 μg |
| 01-07-0138 | Anti-F G(ΔTM)(Strain CAN97-83)(hMPV) | IgG1 | WB, ELISA, IP, IF | 100 μg |
| 01-07-0139 | Anti-F G(ΔTM)(Strain CAN97-83)(hMPV) | IgG1 | ELISA, IP, IF | 100 μg |
| 01-07-0140 | Anti-F (RSV) 101F (human Fc) | IgG1 | Neutralization, ELISA, IF, etc. | 100 μg |
| 01-07-0141 | Anti-F (RSV) Palivizumab | IgG1 | Neutralization, ELISA, IF, etc. | 100 μg |
| 01-07-0142 | Anti-F (RSV) MPE8 | IgG1 | Neut., ELISA, IP, IF | 100 μg |
| 01-07-0143 | Anti-F (RSV) 5C4 | IgG1 | Neutralization, ELISA, IF, etc. | 100ug |
| 01-07-0144 | Anti-F (RSV) AM22 (human Fc) | IgG1 | WB standard, antibody ELISA, immunogen, etc | 100ug |
| 01-07-0145 | Anti-F (RSV) CR9501 | IgG1 | Neutralization, ELISA, IF, etc. | 100 ug |
MSDS
온라인 견적